NuChem Therapeutics Overview
- Founded
- 2011
- Status
- Private
- Latest Deal Type
- Buyout/LBO
- Investors
- 6
NuChem Therapeutics General Information
Description
Provider of medical contract research services intended to identify and optimize pre-clinical candidates in the area of small molecule drug discovery. The company's services specialize in the field of medicinal chemistry, drug discovery biology and can provide custom synthesis of compounds, structure-activity-relationship design, DMPK services, computational drug design, enabling companies to move their project forward quickly and efficiently.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Discovery Tools (Healthcare)
Primary Office
- 2350 rue Cohen
- Saint-Laurent
- Montreal, Quebec H4R 2N6
- Canada
+1 (514) 000-0000
NuChem Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Buyout/LBO (MBO) | 22-Feb-2019 | Completed | Generating Revenue | |||
| 1. Seed Round | 03-Apr-2012 | Completed | Generating Revenue |
NuChem Therapeutics Executive Team (5)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Marc LeBel | President & Board Member | ||
| Daniel Guay Ph.D | Chief Scientific Officer | ||
| Lynda Choquette | Director, Finance | ||
| Inès Holzbaur Ph.D | President |
NuChem Therapeutics Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Louis Lacasse | GeneChem | Board Member | 000 0000 |
| Marc LeBel | NuChem Therapeutics | President & Board Member | 000 0000 |
NuChem Therapeutics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Fonds de solidarité FTQ | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Investissement Québec | Venture Capital | Minority | 000 0000 | 000000 0 | |
| GeneChem | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Institut De Recherche Clinique De Montreal | Corporation | Minority | 000 0000 | 000000 0 | |
| Nabil Seidah | Corporation | Minority | 000 0000 | 000000 0 |
NuChem Therapeutics Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 000000000 | 31-Oct-2019 | 0000000000 | Drug Discovery | 0000 00000 |
NuChem Therapeutics Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 000000 000000000 | Drug Discovery | Montreal, Canada | 0000 |